SINHA UMA (Chief Scientific Officer) sold 3.2% of their position (10K shares) of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.24M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 1/15/2021ACC: 0000899243-21-002179
Officer· Chief Scientific Officer
Since Nov 2018
-10K
Net shares
Net seller
$1.24M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
10K disposed
Non-Derivative Transactions6
Common Stock
Direct
Shares
−696.00
Price / share
$121.11
Trade value
$84.29K
% of position
0.2%
1/13/2021
316.52K→315.83K
Common Stock
Direct
Shares
−572.00
Price / share
$122.27
Trade value
$69.94K
% of position
0.2%
1/13/2021
315.83K→315.26K
Common Stock
Direct
Shares
−1.50K
Price / share
$123.48
Trade value
$184.97K
% of position
0.5%
1/13/2021
315.26K→313.76K
Common Stock
Direct
Shares
−4.93K
Price / share
$124.72
Trade value
$615.36K
% of position
1.6%
1/13/2021
313.76K→308.82K
Common Stock
Direct
Shares
−2K
Price / share
$125.35
Trade value
$250.70K
% of position
0.6%
1/13/2021
308.82K→306.82K
Common Stock
Direct
Shares
−300.00
Price / share
$126.39
Trade value
$37.92K
% of position
0.1%
1/13/2021
306.82K→306.52K
Total
Net shares
−10K
Net value
-$1.24M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2021 | S · Sale | −696.00 | $121.11 | $84.29K | 0.2% | 316.52K | 315.83K |
| Common Stock Direct | 1/13/2021 | S · Sale | −572.00 | $122.27 | $69.94K | 0.2% | 315.83K | 315.26K |
| Common Stock Direct | 1/13/2021 | S · Sale | −1.50K | $123.48 | $184.97K | 0.5% | 315.26K | 313.76K |
| Common Stock Direct | 1/13/2021 | S · Sale | −4.93K | $124.72 | $615.36K | 1.6% | 313.76K | 308.82K |
| Common Stock Direct | 1/13/2021 | S · Sale | −2K | $125.35 | $250.70K | 0.6% | 308.82K | 306.82K |
| Common Stock Direct | 1/13/2021 | S · Sale | −300.00 | $126.39 | $37.92K | 0.1% | 306.82K | 306.52K |
| Total | −10K | -$1.24M | ||||||
Derivative Transactions0
No derivative transactions reported